DAVID LEVINTHAL
🇺🇸United States
Clinical Trials
2
Active:1
Completed:0
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)Cerebral Cortical Influences on Autonomic Function
Not Applicable
Active, not recruiting
- Conditions
- Healthy SubjectsFunctional DyspepsiaIrritable Bowel Syndrome
- First Posted Date
- 2019-03-11
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- David Levinthal
- Target Recruit Count
- 244
- Registration Number
- NCT03869372
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Treating Anorectal Dysfunction in MS
Phase 2
Terminated
- Conditions
- ConstipationMultiple SclerosisFecal Incontinence
- Interventions
- Other: Placebo
- First Posted Date
- 2015-11-20
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- David Levinthal
- Target Recruit Count
- 11
- Registration Number
- NCT02609607
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
News
No news found